InnovAgevsThermo Fisher Scientific

INNV and TMO stock compared: price, dividend, valuation and results, from SEC filings.

TMO

Thermo Fisher Scientific Inc

$700.22

Value $260B

+0.11%
TMO's page

InnovAge (INNV) has a market value of $1.3B and Thermo Fisher Scientific (TMO) $260B. Over the last year, with dividends, INNV moved +66.4% and TMO +19.5%. The P/E is 143.6 for INNV and 36.8 for TMO. Dividend yield: INNV none, TMO 0.26%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    INNV$1.3B

    TMO$260B

    TMO is 201 times INNV

  • Revenue, 12 months

    INNV$1.0B

    TMO$47.4B

    TMO is 46 times INNV

  • Net income, 12 months

    INNV$9.0M

    TMO$7.1B

    TMO is 786 times INNV

  • Operating margin

    INNV1.4%

    TMO17.9%

    16.5 points apart

  • ROIC

    INNV3.8%

    TMO8.2%

    4.4 points apart

  • P/E

    INNV143.6

    TMO36.8

    INNV is 3.9 times TMO

  • Dividend yield

    INNV0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    INNV+8.4%

    TMO+11.8%

    3.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

INNV+8.3%

TMO+11.8%

5010020222023202420252026
Returns by period
PeriodINNVWith dividendsTMOWith dividends
1 year since November 12, 2025+66.4%Price +66.4%+19.5%Price +19.1%
3 years since November 13, 2023+67.9%+18.9% a yearPrice +67.9%+58.8%+16.7% a yearPrice +57.3%
5 years since November 12, 2021+8.4%+1.6% a yearPrice +8.4%+11.8%+2.3% a yearPrice +10.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

INNVInnovAgeTMOThermo Fisher Scientific

Valuation

INNVTMO
Valuation
Price$9.47$700.22
Market value$1.3B$260B
Enterprise value (EV)$1.2B$295B
P/E143.636.8
P/E, 5-year median–32.7
P/B5.14.8
EV/EBIT82.234.9
Free cash flow yield5.9%2.9%

Results and growth

INNVTMO
Results and growth
Revenue, 12 months$1.0B$47.4B
Net income, 12 months$9.0M$7.1B
Free cash flow, 12 months$76M$7.6B
Earnings per share, 12 months$0.06$18.96
Revenue growth, year on year15.9%3.9%
Revenue growth a year, past+9.2%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

INNVTMO
Margins and returns on capital
Gross margin23.6%–
Operating margin1.4%17.9%
Net margin0.9%14.9%
ROIC3.8%8.2%
ROE3.7%13.4%

Balance sheet

INNVTMO
Balance sheet
Cash$163M$6.1B
Total debt$84M$41.4B
Net debt / EBITDA-2.93.7
Interest cover–5.5×

Dividends and buybacks

INNVTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: INNV or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, InnovAge or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($260B) is about 201.3 times InnovAge ($1.3B), at today's prices.

How did INNV and TMO stock do over the last 5 years?

Since November 12, 2021, INNV's price moved +8.4% and TMO's +10.2%. With dividends: INNV +8.4% (+1.6% a year), TMO +11.8% (+2.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, INNV or TMO?

The dividend yield at today's price is none for InnovAge and 0.26% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

What is the P/E of INNV and TMO?

At today's price, the P/E is 143.6 for INNV and 36.8 for TMO. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, InnovAge or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 0.9% for InnovAge and 14.9% for Thermo Fisher Scientific, and the operating margin 1.4% and 17.9%. Revenue was $1.0B and $47.4B.

Which is the better investment, InnovAge or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.